1. A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer. (September 2017) Authors: Park, Sook Ryun; Kim, Mi-Jung; Nam, Byung-Ho; Kim, Chan Gyoo; Lee, Jong Yeul; Cho, Soo-Jeong; Kong, Sun-Young; Park, Young-Iee Journal: European journal of cancer Issue: Volume 83(2017) Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status: clinical and pharmacogenetic results. Issue 1 (January 2018) Authors: Kim, Mi-Jung; Kong, Sun-Young; Nam, Byung-Ho; Kim, Sohee; Park, Young-Iee; Park, Sook Ryun Journal: Pharmaocogenetics and genomics Issue: Volume 28:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer. (July 2009) Authors: Kong, Sun-Young; Lim, Hyeong-Seok; Nam, Byung-Ho; Kook, Myeong-Cherl; Kim, Young-Woo; Won Ryu, Keun; Lee, Jun Ho; Choi, Il Ju; Lee, Jin Soo; Park, Young-Iee; Kim, Noe Kyeong; Park, Sook Ryun Journal: Pharmacogenomics Issue: Volume 10:Number 7(2009) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗